Clinical presentation, treatment and outcome of focal segmental glomerulosclerosis in Far North Queensland Australian adults-Reference-Cited by-同舟云学术

Clinical presentation, treatment and outcome of focal segmental glomerulosclerosis in Far North Queensland Australian adults

Published:2017-06-15 Issue:7 Volume:22 Page:520-530
ISSN:1320-5358
Container-title:Nephrology
language:en
Short-container-title:Nephrology

Author:

Greenwood Alice M¹²,Gunnarsson Ronny¹³⁴,Neuen Brendon L¹⁵,Oliver Kimberley⁶,Green Stella J²,Baer Richard A²

Affiliation:

1. College of Medicine and Dentistry; James Cook University; Cairns Queensland Australia

2. Department of Renal Medicine; Cairns Hospital; Cairns Queensland Australia

3. Research and Development Unit; Primary Health Care and Dental Care; Southern Älvsborgy Västra Götaland Sweden

4. Department of Public Health and Community Medicine, Institute of Medicine, The Sahlgrenska Academy; University of Gothenburg; Gothenburg Sweden

5. The George Institute for Global Health; Royal Prince Alfred Hospital; Camperdown NSW

6. Pathology Queensland; Queensland Health; Brisbane Queensland Australia

Publisher

Wiley

Subject

Nephrology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/nep.12816/fullpdf

Reference29 articles.

1. Focal segmental glomerulosclerosis;D'Agati;N. Engl. J. Med.,2011

2. Primary focal segmental glomerulosclerosis;Korbet;J. Am. Soc. Nephrol.,1998 Jul

3. Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment;Rydel;Am. J. Kidney Dis.,1995 Apr

4. Blair Grace KH S McDonald ANZDATA registry report 2012: new patients 2012

5. United States renal data system 2010 annual data report: atlas of chronic kidney disease & end-stage renal disease in the United States;Collins RNF;Am. J. Kidney Dis.,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Immunosuppressive Therapy in Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis;Kidney Medicine;2022-08

2. Efficacy and Safety of ACE Inhibitor and Angiotensin Receptor Blocker Therapies in Primary Focal Segmental Glomerulosclerosis Treatment: A Systematic Review and Meta-Analysis;Kidney Medicine;2022-05

3. Idiopathic Nephrotic Syndrome: Characteristics and Identification of Prognostic Factors;Journal of Clinical Medicine;2018-09-09